SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-109439
Filing Date
2008-05-09
Accepted
2008-05-09 13:56:28
Documents
5
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 525862
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 5445
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 5416
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2986
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2957
  Complete submission text file 0001193125-08-109439.txt   544112
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33415 | Film No.: 08817530
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1